Researchers Identify Key Signaling Pathway Disruptions Driving Breast Cancer Treatment Resistance

Researchers Identify Key Signaling Pathway Disruptions Driving Breast Cancer Treatment Resistance

Source: Pharmacy Times

The findings provide a deeper understanding of the mechanisms underlying breast cancer progression and treatment resistance.

Researchers from Brown University discover that disruptions in signaling pathways, namely PI3K/Akt/mTOR, drive oncogenesis and poor treatment responses in breast cancer (BC). Their findings, published in Oncotarget, may provide a deeper look into the… [4013 chars]

Read more